- Home
- ACHV vs CIK Comparison
ACHV vs CIK Comparison
Compare ACHV & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- CIK
- Stock Information
- Founded
- ACHV N/A
- CIK 1987
- Country
- ACHV Canada
- CIK United States
- Employees
- ACHV N/A
- CIK N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CIK Finance/Investors Services
- Sector
- ACHV Health Care
- CIK Finance
- Exchange
- ACHV Nasdaq
- CIK Nasdaq
- Market Cap
- ACHV 137.6M
- CIK 158.7M
- IPO Year
- ACHV N/A
- CIK N/A
- Fundamental
- Price
- ACHV $3.69
- CIK $2.92
- Analyst Decision
- ACHV Strong Buy
- CIK
- Analyst Count
- ACHV 5
- CIK 0
- Target Price
- ACHV $14.80
- CIK N/A
- AVG Volume (30 Days)
- ACHV 142.3K
- CIK 115.4K
- Earning Date
- ACHV 11-07-2024
- CIK 01-01-0001
- Dividend Yield
- ACHV N/A
- CIK 9.03%
- EPS Growth
- ACHV N/A
- CIK N/A
- EPS
- ACHV N/A
- CIK N/A
- Revenue
- ACHV N/A
- CIK N/A
- Revenue This Year
- ACHV N/A
- CIK N/A
- Revenue Next Year
- ACHV N/A
- CIK N/A
- P/E Ratio
- ACHV N/A
- CIK N/A
- Revenue Growth
- ACHV N/A
- CIK N/A
- 52 Week Low
- ACHV $3.41
- CIK $2.50
- 52 Week High
- ACHV $5.59
- CIK $3.19
- Technical
- Relative Strength Index (RSI)
- ACHV 26.02
- CIK 35.47
- Support Level
- ACHV $4.07
- CIK $2.85
- Resistance Level
- ACHV $4.21
- CIK $3.02
- Average True Range (ATR)
- ACHV 0.22
- CIK 0.03
- MACD
- ACHV -0.06
- CIK -0.01
- Stochastic Oscillator
- ACHV 8.49
- CIK 20.00
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations, and individuals.